TL1A as a Potential Local Inducer of IL17A Expression in Colon Mucosa of Inflammatory Bowel Disease Patients

Scandinavian Journal of Immunology

Volumn 82, Issue 4, 2015, Pages 352-360

  Slebioda T J ^a   Bojarska Junak, A ^b   Stanislawowski M ^a   Cyman, M ^a   Wierzbicki, P M ^a   Rolinski J ^b   Celinski K ^b   Kmiec Z ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID DERIVATIVE; AZATHIOPRINE; DEATH RECEPTOR 3; GAMMA INTERFERON; HERMES ANTIGEN; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; L SELECTIN; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; TRANSCRIPTION FACTOR FOXP3; VASCULAR ENDOTHELIAL GROWTH INHIBITOR; IL17A PROTEIN, HUMAN; IL4 PROTEIN, HUMAN; TNFRSF25 PROTEIN, HUMAN; TNFSF15 PROTEIN, HUMAN;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; COLON MUCOSA; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATORY BOWEL DISEASE; INTESTINE CELL; LAMINA PROPRIA; MALE; MONONUCLEAR CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ULCERATIVE COLITIS; UPREGULATION; BIOSYNTHESIS; BLOOD; COLON; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; MIDDLE AGED;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; ENTEROCYTES; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-13; INTERLEUKIN-17; INTERLEUKIN-4; INTESTINAL MUCOSA; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 25; RNA, MESSENGER; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15; UP-REGULATION;

EID: 84941132824     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12324     Document Type: Article

References (40)

1. Jager S, Stange EF, Wehkamp J. Inflammatory bowel disease: an impaired barrier disease. Langenbecks Arch Surg 2013;398:1-12.
2. Molodecky NA, Kaplan GG. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (N Y) 2010;6:339-46.
3. Brand S. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 2009;58:1152-67.
4. Bamias G, Kaltsa G, Ladas SD. Cytokines in the pathogenesis of ulcerative colitis. Discov Med 2011;11:459-67.
5. Muzes G, Molnar B, Tulassay Z, Sipos F. Changes of the cytokine profile in inflammatory bowel diseases. World J Gastroenterol 2012;18:5848-61.
6. Bamias G, Martin C 3rd, Marini M et al. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J Immunol 2003;171:4868-74.
7. Prehn JL, Mehdizadeh S, Landers CJ et al. Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation. Clin Immunol 2004;112:66-77.
8. Kamada N, Hisamatsu T, Honda H et al. TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohn's disease. Inflamm Bowel Dis 2010;16:568-75.
9. Bamias G, Kaltsa G, Siakavellas SI et al. High intestinal and systemic levels of decoy receptor 3 (DcR3) and its ligand TL1A in active ulcerative colitis. Clin Immunol 2010;137:242-9.
10. Bamias G, Kaltsa G, Siakavellas SI et al. Differential expression of the TL1A/DcR3 system of TNF/TNFR-like proteins in large vs. small intestinal Crohn's disease. Dig Liver Dis 2012;44:30-6.
11. Yu KY, Kwon B, Ni J, Zhai Y, Ebner R, Kwon BS. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem 1999;274:13733-6.
12. Pitti RM, Marsters SA, Lawrence DA et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 1998;396:699-703.
13. Takedatsu H, Michelsen KS, Wei B et al. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology 2008;135:552-67.
14. Prehn JL, Thomas LS, Landers CJ, Yu QT, Michelsen KS, Targan SR. The T cell costimulator TL1A is induced by FcgammaR signaling in human monocytes and dendritic cells. J Immunol 2007;178:4033-8.
15. Kim S, Zhang L. Identification of naturally secreted soluble form of TL1A, a TNF-like cytokine. J Immunol Methods 2005;298:1-8.
16. Cavallini C, Lovato O, Bertolaso A et al. The TNF-family cytokine TL1A inhibits proliferation of human activated B cells. PLoS ONE 2013;8:e60136.
17. Meylan F, Davidson TS, Kahle E et al. The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Immunity 2008;29:79-89.
18. Slebioda TJ, Rowley TF, Ferdinand JR et al. Triggering of TNFRSF25 promotes CD8(+) T-cell responses and anti-tumor immunity. Eur J Immunol 2011;41:2606-11.
19. Fang L, Adkins B, Deyev V, Podack ER. Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation. J Exp Med 2008;205:1037-48.
20. Zhou M, Liu R, Su D, Feng X, Li X. TL1A increased the differentiation of peripheral Th17 in rheumatoid arthritis. Cytokine 2014;69:125-130.
21. Shih DQ, Barrett R, Zhang X et al. Constitutive TL1A (TNFSF15) expression on lymphoid or myeloid cells leads to mild intestinal inflammation and fibrosis. PLoS ONE 2011;6:e16090.
22. Zheng L, Zhang X, Chen J et al. Sustained Tl1a expression on both lymphoid and myeloid cells leads to mild spontaneous intestinal inflammation and fibrosis. Eur J Microbiol Immunol (Bp) 2013;3:11-20.
23. Taraban VY, Slebioda TJ, Willoughby JE et al. Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia. Mucosal Immunol 2011;4:186-96.
24. Meylan F, Song YJ, Fuss I et al. The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation. Mucosal Immunol 2011;4:172-85.
25. Yamamoto S, Nakase H, Mikami S et al. Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis. Aliment Pharmacol Ther 2008;28:589-97.
26. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439-44.
27. Park MH, Song MJ, Cho MC et al. Interleukin-32 enhances cytotoxic effect of natural killer cells to cancer cells via activation of death receptor 3. Immunology 2012;135:63-72.
28. Xiu Z, Shen H, Tian Y, Xia L, Lu J. Serum and synovial fluid levels of tumor necrosis factor-like ligand 1A and decoy receptor 3 in rheumatoid arthritis. Cytokine 2015;72:185-9.
29. Li L, Fu L, Lu Y et al. TNF-like ligand 1A is associated with the pathogenesis of psoriasis vulgaris and contributes to IL-17 production in PBMCs. Arch Dermatol Res 2014;306:927-32.
30. Qin T. Upregulation of DR3 expression in CD4(+) T cells promotes secretion of IL-17 in experimental autoimmune uveitis. Mol Vis 2011;17:3486-93.
31. Biancheri P, Pender SL, Ammoscato F et al. The role of interleukin 17 in Crohn's disease-associated intestinal fibrosis. Fibrogenesis Tissue Repair 2013;6:13.
32. O'Connor W Jr, Kamanaka M, Booth CJ et al. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol 2009;10:603-9.
33. Kleinschek MA, Boniface K, Sadekova S et al. Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J Exp Med 2009;206:525-34.
34. Cohavy O, Shih DQ, Doherty TM, Ware CF, Targan SR. Cd161 defines effector T cells that express light and respond to Tl1a-Dr3 signaling. Eur J Microbiol Immunol (Bp) 2011;1:70-9.
35. Fujino S, Andoh A, Bamba S et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003;52:65-70.
36. Baeten DL, Kuchroo VK. How Cytokine networks fuel inflammation: Interleukin-17 and a tale of two autoimmune diseases. Nat Med 2013;19:824-5.
37. Sutton CE, Mielke LA, Mills KH. IL-17-producing gammadelta T cells and innate lymphoid cells. Eur J Immunol 2012;42:2221-31.
38. Gu C, Wu L, Li X. IL-17 family: cytokines, receptors and signaling. Cytokine 2013;64:477-485.
39. Papadakis KA, Prehn JL, Landers C et al. TL1A synergizes with IL-12 and IL-18 to enhance IFN-gamma production in human T cells and NK cells. J Immunol 2004;172:7002-7.
40. Hirota K, Ahlfors H, Duarte JH, Stockinger B. Regulation and function of innate and adaptive interleukin-17-producing cells. EMBO Rep 2012;13:113-20.